Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1150 of 3173 entries
View as:

Study Of Sunitinib With Capecitabine In Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00662025 Org: User:
Start: 04/30/08 End: 05/31/12 Due: 05/31/13

Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT05132101 Org: User:
Start: 12/20/21 End: 03/14/22 Due: 03/14/23

Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone

Phase: N/A Priority: Normal
NCT ID: NCT00282945 Org: User:
Start: 01/31/06 End: 10/31/07 Due: 10/31/08

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05386472 Org: User:
Start: 06/22/22 End: 05/25/25 Due: 05/25/26

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Phase: N/A Priority: Normal
NCT ID: NCT07028853 Org: User:
Start: 08/25/25 End: 12/08/34 Due: 12/08/35

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00600821 Org: User:
Start: 04/30/08 End: 10/31/12 Due: 10/31/13

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT07029711 Org: User:
Start: 07/14/25 End: 05/30/27 Due: 05/30/28

Phase 1 Thorough QT (TQT) Study in Young Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00809289 Org: User:
Start: 12/31/08 End: 07/31/09 Due: 07/31/10

Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults

Phase: N/A Priority: Normal
NCT ID: NCT03732638 Org: User:
Start: 11/14/18 End: 02/02/21 Due: 02/02/22

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00113516 Org: User:
Start: 09/30/05 End: 03/31/09 Due: 03/31/10

Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01140425 Org: User:
Start: 07/31/10 End: 12/31/10 Due: 12/31/11

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00034957 Org: User:
Start: - End: 10/31/02 Due: 10/31/03

A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00002085 Org: User:
Start: - End: - Due: -

A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06507904 Org: User:
Start: 04/17/26 End: 10/31/26 Due: 10/31/27

A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee

Phase: N/A Priority: Normal
NCT ID: NCT00420992 Org: User:
Start: 12/31/06 End: 11/30/07 Due: 11/30/08

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06717425 Org: User:
Start: 12/09/24 End: 12/04/25 Due: 12/04/26

Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT05361655 Org: User:
Start: 09/01/21 End: 09/01/21 Due: 09/01/22

A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00928070 Org: User:
Start: 09/30/09 End: 09/30/11 Due: 09/30/12

Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting

Phase: N/A Priority: Normal
NCT ID: NCT01838057 Org: User:
Start: 06/30/13 End: 07/31/14 Due: 07/31/15

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

Phase: N/A Priority: Normal
NCT ID: NCT01176916 Org: User:
Start: 02/09/11 End: 11/30/18 Due: 11/30/19

A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00859807 Org: User:
Start: 05/31/09 End: 06/30/09 Due: 06/30/10

A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

Phase: N/A Priority: Normal
NCT ID: NCT04671615 Org: User:
Start: 12/06/20 End: 01/01/23 Due: 01/01/24

Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03565991 Org: User:
Start: 06/18/18 End: 02/03/23 Due: 02/03/24

A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01484561 Org: User:
Start: 04/30/12 End: 02/28/13 Due: 02/28/14

Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00838383 Org: User:
Start: 08/10/06 End: 03/31/08 Due: 03/31/09